Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry

Despite the withdrawal of the HeartWare Ventricular Assist Device (HVAD), hundreds of patients are still supported with this continuous-flow pump, and the long-term management of these patients is still under debate. This study aims to analyse 5 years survival and freedom from major adverse events i...

Descripción completa

Detalles Bibliográficos
Autores principales: Francica, Alessandra, Loforte, Antonio, Attisani, Matteo, Maiani, Massimo, Iacovoni, Attilio, Nisi, Teodora, Comisso, Marina, Terzi, Amedeo, De Bonis, Michele, Vendramin, Igor, Boffini, Massimo, Musumeci, Francesco, Luciani, Giovanni Battista, Rinaldi, Mauro, Pacini, Davide, Onorati, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505657/
https://www.ncbi.nlm.nih.gov/pubmed/37727385
http://dx.doi.org/10.3389/ti.2023.11675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505657/
https://www.ncbi.nlm.nih.gov/pubmed/37727385
http://dx.doi.org/10.3389/ti.2023.11675

Ejemplares similares